Health Ministry permits the sale of Oseltamivir Phosphate and Zanamivir akin to Schedule H1 drugs, with restrictions on sale and export regulated by the Government and DCGI
Ministry of Health and Family Welfare has issued a Notification dated February 5, 2024, revoking... Read More
Public comments invited on proposed amendments to First and Second Schedule of the Drugs and Cosmetics Act till 12th April, 2023
The Ministry of Ayush has invited objections and suggestions on proposed amendments to Schedule I... Read More
CDSCO issues FAQ for implementation Barcode requirement on the label of 300 brands of drugs
Central Drugs Standard Control Organization has issued a FAQ for implementation of the requirement... Read More
NPPA extends date for filing quarterly returns for quarter ended September, 2022 and MRP revisions of scheduled and non-scheduled drugs and medical devices till 31st December, 2022
You need to be logged in to view this content. Please Log In. Not a Member? Join... Read More